SE418744B - Foreningar till anvendning som mellanprodukter vid framstellning av prostaglandiner - Google Patents

Foreningar till anvendning som mellanprodukter vid framstellning av prostaglandiner

Info

Publication number
SE418744B
SE418744B SE7608224A SE7608224A SE418744B SE 418744 B SE418744 B SE 418744B SE 7608224 A SE7608224 A SE 7608224A SE 7608224 A SE7608224 A SE 7608224A SE 418744 B SE418744 B SE 418744B
Authority
SE
Sweden
Prior art keywords
prostaglandines
associations
intermediates
production
Prior art date
Application number
SE7608224A
Other languages
English (en)
Other versions
SE7608224L (sv
Inventor
T K Schaaf
L J Czuba
H-J E Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7608224L publication Critical patent/SE7608224L/sv
Publication of SE418744B publication Critical patent/SE418744B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
SE7608224A 1972-06-07 1976-07-19 Foreningar till anvendning som mellanprodukter vid framstellning av prostaglandiner SE418744B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26051872A 1972-06-07 1972-06-07

Publications (2)

Publication Number Publication Date
SE7608224L SE7608224L (sv) 1976-07-19
SE418744B true SE418744B (sv) 1981-06-22

Family

ID=22989486

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7307522A SE415883B (sv) 1972-06-07 1973-05-28 Forfarande for framstellning av n-substituerade prostaglandinkarboxamider
SE7608225A SE7608225L (sv) 1972-06-07 1976-07-19 Forfarande for framstellning av prostaglandiner
SE7608224A SE418744B (sv) 1972-06-07 1976-07-19 Foreningar till anvendning som mellanprodukter vid framstellning av prostaglandiner

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE7307522A SE415883B (sv) 1972-06-07 1973-05-28 Forfarande for framstellning av n-substituerade prostaglandinkarboxamider
SE7608225A SE7608225L (sv) 1972-06-07 1976-07-19 Forfarande for framstellning av prostaglandiner

Country Status (24)

Country Link
JP (2) JPS5715591B2 (sv)
AR (1) AR207434A1 (sv)
AT (1) AT340069B (sv)
BE (1) BE800580A (sv)
CA (1) CA985280A (sv)
CH (3) CH605887A5 (sv)
CS (1) CS200166B2 (sv)
DD (2) DD115687A5 (sv)
DE (1) DE2329092A1 (sv)
ES (3) ES415611A1 (sv)
FI (1) FI58327C (sv)
FR (2) FR2187344B1 (sv)
GB (2) GB1439511A (sv)
HU (3) HU170200B (sv)
IE (1) IE38058B1 (sv)
IL (2) IL42385A (sv)
IN (1) IN138966B (sv)
LU (1) LU67754A1 (sv)
NL (2) NL160814C (sv)
NO (2) NO146538C (sv)
PH (2) PH14204A (sv)
SE (3) SE415883B (sv)
YU (1) YU36498B (sv)
ZA (1) ZA733763B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3291E (es) * 1975-04-23 1980-08-22 Upjohn Co Procedimiento para preparar analogos de prostaglandinas
US6395787B1 (en) 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3187043A (en) * 1962-05-18 1965-06-01 Monsanto Co Monohalophosphonium halides

Also Published As

Publication number Publication date
FI58327C (fi) 1981-01-12
JPS5715591B2 (sv) 1982-03-31
AU5643173A (en) 1974-12-05
DD115687A5 (sv) 1975-10-12
AR207434A1 (es) 1976-10-08
CH591511A5 (sv) 1977-09-30
JPS5731692A (en) 1982-02-20
JPS4954350A (sv) 1974-05-27
CH593929A5 (sv) 1977-12-30
IL42385A0 (en) 1973-07-30
IE38058B1 (en) 1977-12-21
FI58327B (fi) 1980-09-30
FR2273814B1 (sv) 1977-07-08
IN138966B (sv) 1976-04-17
PH14204A (en) 1981-04-01
AT340069B (de) 1977-11-25
CS200166B2 (en) 1980-08-29
SE7608225L (sv) 1976-07-19
NO146538C (no) 1982-10-20
IL51525A0 (en) 1977-04-29
NO142784B (no) 1980-07-07
ZA733763B (en) 1974-04-24
HU170487B (sv) 1977-06-28
NL160814B (nl) 1979-07-16
HU170491B (sv) 1977-06-28
NL160814C (nl) 1979-12-17
BE800580A (fr) 1973-12-07
DD109211A5 (sv) 1974-10-20
PH13092A (en) 1979-11-27
FR2187344A1 (sv) 1974-01-18
CA985280A (en) 1976-03-09
ES430416A1 (es) 1976-10-16
IL42385A (en) 1979-10-31
NO146538B (no) 1982-07-12
ES415611A1 (es) 1976-07-16
ATA504873A (de) 1977-03-15
FR2273814A1 (fr) 1976-01-02
SE415883B (sv) 1980-11-10
LU67754A1 (sv) 1973-12-14
NL7812163A (nl) 1979-04-27
YU36498B (en) 1984-02-29
FR2187344B1 (sv) 1977-10-28
ES430417A1 (es) 1977-03-01
SE7608224L (sv) 1976-07-19
DE2329092A1 (de) 1974-01-03
GB1439512A (en) 1976-06-16
NO142784C (no) 1980-10-15
YU152673A (en) 1982-02-25
HU170200B (sv) 1977-04-28
CH605887A5 (sv) 1978-10-13
NO740850L (no) 1973-12-10
GB1439511A (en) 1976-06-16
NL7307867A (sv) 1973-12-11
IE38058L (en) 1973-12-07

Similar Documents

Publication Publication Date Title
SE390414B (sv) 14,15-dioxo-e-homo-eburnaner som mellanprodukt for framstellning av vinkamin
SE431756B (sv) Fenoxi-2-oxopropylfosfonat till anvendning som mellanprodukt vid framstellning av nya w-pentanorprostaglandiner
AR199711A1 (es) Procedimiento para obtener penicilinas novedosas
SE387358B (sv) Vid rumstemperatur till elaster vulkbara massor samt butoxiacetoxikiselforeningar for framstellning av massorna
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
FI55802B (fi) Anordning vid skeppsskrov
SE396592B (sv) Foreningen difluorometyl-2,2,3,3-tetrafluoropropyleter till anvendning som mellanprodukt vid framstellning av difluormetyl-1,2,2,3,3-pentafluoropropyleter
FI54192C (fi) Anordning vid s k cyklonugn
FI55908C (fi) Anordning vid aonggenerator
SE401507B (sv) Nya trans-epoxi-cis-alkener avsedda som mellanprodukter for framstellning av prostaglandinderivat
FI54359C (fi) Kalander foer anvaendning vid glaettning av en pappersbana
FI54411C (fi) Anordning vid vaermevaexlare
SE440782B (sv) Steroidspirolaktoner till anvendning som mellanprodukter vid framstellning av spirolaktonsteroider
SE7700287L (sv) Nya foreningar till anvendning som mellanprodukter vid framstellning av aminosubstituerade tetracykliska foreningar
SE7611466L (sv) Mellanforening till anvendning vid framstellning av en ny d-2-substituerad-6-metyl-8-substituerad ergolin
SE418744B (sv) Foreningar till anvendning som mellanprodukter vid framstellning av prostaglandiner
AR195267A1 (es) Procedimiento para la produccion de nuevas penicilinas
FI54023C (fi) Anordning vid eldstaeder uppbyggda av s k membranvaeggar
SE401076B (sv) Karbotiolat av azetidiner till anvendning som herbicid
SE402279B (sv) Vissa angivna 4-cyanofenoxiacetonitriler till anvendning som ogresbekempningsmedel
SE386168B (sv) Nya kinazolinderivat till anvendning som mellanprodukter for framstellning av terapeutisk verdefulla bensoiazepinderivat
SE431210B (sv) 7-alfa-alkoxi cefalosporinderivat till anvendning sasom mellanprodukter vid framstellning av cefalosporinantibiotika
SE418964B (sv) Piperidinyloxiderivat avsedda som mellanprodukter for framstellning av piperidinoalkylfenotiaziner
SE417196B (sv) Propandioler till anvendning som mellanprodukter for framstellning av terapeutiskt verksamma m-dioxan-5-metylaminer
FI54087C (fi) Anordning vid sjaelvstaengande foerslutningar